Abstract
Medulloblastoma is the most common malignant brain tumor in childhood and according to World Health Organization it is subdivided in 4 molecular subgroups: WNT, SHH, Group 3 and Group 4. SHH is divided in SHH TP53 WT and Mutated. These subgroups have distinct molecular characteristics and clinical associations, and differ in the prognosis of patients impacting the risk stratification and …